21867-64-1

Basic information

• Product Name: 1-PROPYLPIPERAZINE
• Synonyms: TIMTEC-BB SBB005871;N-PROPYL PIPERAZINE;1-N-PROPYLPIPERAZINE;1-PROPYLPIPERAZINE;AKOS BBS-00003600;zhengzhou Pacific CheMSource, Inc.;N-n-Propyl piperazine 1-n-Propylpiperazine;N-n-Propyl piperazine
• CAS NO: 21867-64-1
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 128.22
• EINECS: 256-745-9
• Mol File: 21867-64-1.mol

Chemical Properties

• Boiling Point: 176.7 °C at 760 mmHg
• Flash Point: 60.7 °C
• Appearance: /
• Density: 0.868 g/cm³
• Vapor Pressure: 1.08mmHg at 25°C
• Refractive Index: 1.445
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-PROPYLPIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-PROPYLPIPERAZINE(21867-64-1)
• EPA Substance Registry System: 1-PROPYLPIPERAZINE(21867-64-1)

Safety Data

• Hazardous Substances Data: 21867-64-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
1-Propylpiperazine is used as a chemical intermediate for the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides.
Used in Metalworking Fluids:
1-Propylpiperazine is used as a corrosion inhibitor in metalworking fluids, helping to prevent the degradation of metal surfaces during manufacturing processes, thereby extending the life of machinery and tools.
Used in Specialty Chemicals Production:
1-Propylpiperazine serves as a precursor in the production of specialty chemicals, which are used in a wide range of applications, including but not limited to coatings, adhesives, and other industrial products.
Safety Precautions:
Given its potential health risks, 1-Propylpiperazine should be handled with appropriate safety measures to prevent ingestion or inhalation, ensuring the well-being of those who work with this compound.

InChI:InChI=1/C7H16N2/c1-2-5-9-6-3-8-4-7-9/h8H,2-7H2,1H3

Upstream product

• 120-43-4 4-ethoxycarbonylpiperazine 

Downstream Products

• 150208-58-5 1-<(3,4-dichlorophenyl)acetyl>-4-(1-propyl)piperazine 
• 124255-93-2 8-Fluoro-3-methyl-6-oxo-9-(4-propyl-piperazin-1-yl)-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid 
• 77176-47-7 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-methanesulfonamide; hydrochloride 
• 77166-13-3 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-4-methyl-benzenesulfonamide; hydrochloride 
• 77166-28-0 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-4-methoxy-benzenesulfonamide; hydrochloride 
• 736910-19-3 Acetic acid 4-(4-propyl-piperazine-1-carbonyl)-phenyl ester 
• 150208-29-0 1-<2-(3,4-dichlorophenyl)-1-ethyl>-4-(1-propyl)piperazine 
• 110417-69-1 1-((2S,3S)-3-Phenyl-oxiranesulfonyl)-4-propyl-piperazine 

Relevant articles and documents

2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.

2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.